J&J Didn't Warn Of Risperdal Breast-Growth Risk, Jury Told
By Matt Fair ( January 26, 2015, 5:43 PM EST) -- A treating physician told a Philadelphia jury on Monday that a Johnson & Johnson unit had not informed him about the risks associated with the antipsychotic drug Risperdal before he prescribed medication to a 7-year-old autistic boy who went on to grow female breasts....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.